Showing 19,521 - 19,540 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((i decrease) OR (a decrease)) ))', query time: 0.71s Refine Results
  1. 19521

    Data_Sheet_9_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…</p>Conclusion<p>Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. …”
  2. 19522

    Data_Sheet_6_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…</p>Conclusion<p>Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. …”
  3. 19523

    Table_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

    Published 2024
    “…</p>Conclusion<p>Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. …”
  4. 19524

    Table_2_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

    Published 2024
    “…</p>Conclusion<p>Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. …”
  5. 19525

    Data_Sheet_13_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…</p>Conclusion<p>Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. …”
  6. 19526

    Table_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

    Published 2024
    “…</p>Conclusion<p>Although the global age-standardized DALY rate of MS decreased between 1990 and 2019, MS continues to account for a considerable number of DALYs and prevalent cases. …”
  7. 19527

    Supplementary file 2_The effects of vessel speed and size on the lethality of strikes of large whales in U.S. waters.docx by Lance P. Garrison (2469937)

    Published 2025
    “…We found a significant effect of vessel size class on the probability of lethality. …”
  8. 19528

    Supplementary file 2_Meta-analysis of Xiaoyao formula as an adjuvant therapy for treating postpartum depression.docx by Jing Liu (38537)

    Published 2025
    “…Additionally, XYF as an adjuvant therapy also significantly decreased Hamilton Depression Scale scores (standard mean difference [SMD] -1.69; 95% CI -2.37 to -1.01).…”
  9. 19529

    Behavioral characterization of prenatal nicotine exposure (PNE) and control mice. by Rodrigo Vidal (4177060)

    Published 2025
    “…Bottom, PNE mice showed a decreased recognition index percentage compared to control mice (PNE: 24.00 ± 1.03%, n = 6; Control: 53.17 ± 4.09%, n = 6), t = 6,921 df = 10, p < 0,0001. …”
  10. 19530

    Image 3_Effective control of the emerging PEDV G2-c variant with an inactivated autogenous vaccine.png by Huan Xu (38476)

    Published 2025
    “…Background<p>Porcine epidemic diarrhea virus (PEDV) is one of the most significant pathogens threatening the swine industry, causing severe economic losses in China. …”
  11. 19531

    Image 2_Effective control of the emerging PEDV G2-c variant with an inactivated autogenous vaccine.png by Huan Xu (38476)

    Published 2025
    “…Background<p>Porcine epidemic diarrhea virus (PEDV) is one of the most significant pathogens threatening the swine industry, causing severe economic losses in China. …”
  12. 19532

    Table 2_Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies.docx by Yutao Liu (87989)

    Published 2025
    “…The primary outcomes included relapse rates, Expanded Disability Status Scale (EDSS) scores, and survival outcomes.</p>Results<p>(1) Anti-CTD Abs (+): higher proportion of female patients, increased relapse frequency; decreased red blood cell (RBC) count and aspartate aminotransferase (AST) levels. (2) ATAbs (+): greater incidence of acute brainstem syndrome (ABS); reduced peripheral leukocyte, neutrophil, and lymphocyte counts; elevated serum urea levels. (3) Double (+): marked female predominance, higher incidence of ABS, decreased RBC count, hemoglobin (Hb) levels, and cerebrospinal fluid (CSF) chloride concentration; elevated serum urea. (4) AQP4-IgG association: AQP4-IgG-positive patients were more frequently female, with higher prevalence of anti-CTD Abs positivity but lower prevalence of ATAbs positivity. (5) Prognostic analysis: both double-positive and single-antibody-positive groups showed higher disability (EDSS ≥4.0/≥6.0) compared with antibody-negative patients, although no significant differences were observed between the two single-antibody subgroups. (6) Multivariate analysis identified combined antibody positivity (OR = 16.292), baseline EDSS score (OR = 3.179), and age at onset (OR = 1.052) as independent predictors of poor clinical outcomes.…”
  13. 19533

    Table 4_Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies.docx by Yutao Liu (87989)

    Published 2025
    “…The primary outcomes included relapse rates, Expanded Disability Status Scale (EDSS) scores, and survival outcomes.</p>Results<p>(1) Anti-CTD Abs (+): higher proportion of female patients, increased relapse frequency; decreased red blood cell (RBC) count and aspartate aminotransferase (AST) levels. (2) ATAbs (+): greater incidence of acute brainstem syndrome (ABS); reduced peripheral leukocyte, neutrophil, and lymphocyte counts; elevated serum urea levels. (3) Double (+): marked female predominance, higher incidence of ABS, decreased RBC count, hemoglobin (Hb) levels, and cerebrospinal fluid (CSF) chloride concentration; elevated serum urea. (4) AQP4-IgG association: AQP4-IgG-positive patients were more frequently female, with higher prevalence of anti-CTD Abs positivity but lower prevalence of ATAbs positivity. (5) Prognostic analysis: both double-positive and single-antibody-positive groups showed higher disability (EDSS ≥4.0/≥6.0) compared with antibody-negative patients, although no significant differences were observed between the two single-antibody subgroups. (6) Multivariate analysis identified combined antibody positivity (OR = 16.292), baseline EDSS score (OR = 3.179), and age at onset (OR = 1.052) as independent predictors of poor clinical outcomes.…”
  14. 19534

    Table 3_Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies.docx by Yutao Liu (87989)

    Published 2025
    “…The primary outcomes included relapse rates, Expanded Disability Status Scale (EDSS) scores, and survival outcomes.</p>Results<p>(1) Anti-CTD Abs (+): higher proportion of female patients, increased relapse frequency; decreased red blood cell (RBC) count and aspartate aminotransferase (AST) levels. (2) ATAbs (+): greater incidence of acute brainstem syndrome (ABS); reduced peripheral leukocyte, neutrophil, and lymphocyte counts; elevated serum urea levels. (3) Double (+): marked female predominance, higher incidence of ABS, decreased RBC count, hemoglobin (Hb) levels, and cerebrospinal fluid (CSF) chloride concentration; elevated serum urea. (4) AQP4-IgG association: AQP4-IgG-positive patients were more frequently female, with higher prevalence of anti-CTD Abs positivity but lower prevalence of ATAbs positivity. (5) Prognostic analysis: both double-positive and single-antibody-positive groups showed higher disability (EDSS ≥4.0/≥6.0) compared with antibody-negative patients, although no significant differences were observed between the two single-antibody subgroups. (6) Multivariate analysis identified combined antibody positivity (OR = 16.292), baseline EDSS score (OR = 3.179), and age at onset (OR = 1.052) as independent predictors of poor clinical outcomes.…”
  15. 19535

    Exploring the effects of COVID-19 on verbal memory function in schizophrenia: Multiple case study and brief literature review by Barbora Keřková (15125926)

    Published 2024
    “…Compared to their matches, COVID-19 positive cases did not show mutually consistent changes in verbal memory performance: one case experienced a significant decline in verbal memory and learning, while the other showed a general normalization of test scores. …”
  16. 19536

    Data Sheet 2_Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer.zip by Hongwei Lan (18849035)

    Published 2025
    “…In PBMC-PDX models, treatment evaluation showed that anlotinib decreased tumor volume, an effect further enhanced by its combination with aPD-L1. scRNA-seq analysis demonstrated that anlotinib reduced the proportions of myofibroblastic cancer-associated fibroblasts and ESM1<sup>+</sup> endothelial cells, resulting in decreased angiogenesis. …”
  17. 19537

    GnRH antagonist impairs the process of embryo implantation by inhibiting motility of endometrial stromal cells through reducing c-kit expression by Jun Tan (46388)

    Published 2024
    “…</i> 56.1%, <i>p</i> < .001) in the GnRH-ant group were significantly decreased. …”
  18. 19538

    Video (Efficacy of uterine manipulator in total abdominal hysterectomy) by Murat Levent Dereli (17763348)

    Published 2025
    “…The manipulator group experienced a decreased postoperative hematocrit drop of 15.9 g/dl (p <0.001). …”
  19. 19539

    Studying Responses of Drosophila Brain After Laser Induced ShockWave Damage by Sonia Kang (22347570)

    Published 2025
    “…However, higher laser powers (630 mW) were required to observe significant cell death, suggesting that LIS must exceed a threshold to induce damage in this model. …”
  20. 19540

    Image 2_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.tif by Fengge Wang (4347442)

    Published 2025
    “…However, the dramatically elevated abundance of these microorganisms was markedly decreased by AS IV treatment. In contrast, compared to GDM rats without treatment, GDM rats treated with AS IV showed a significantly higher abundance of bacteria (p < 0.05), such as Methanobrevibacter, Dubosiella, and Romboutsia, which are beneficial to the rats. …”